PHARMA MAR, S.A.
88Patents
32Active
88Granted
48Portfolio score
Filing activity: Sep 9, 1993 → Aug 10, 2023 · 19 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7482429B2 | Kahalalide F and related compounds | Human Necessities | 26 | Expired |
| US6867334B2 | Metabolites of ecteinascidin 743 formed by human cytochrome CYP3A4 | Chemistry; Metallurgy | 22 | Expired |
| US5786492A | Halichondrins | Chemistry; Metallurgy | 20 | Expired |
| US7309601B2 | Sequences from an endosymbiont and their uses | Human Necessities | 19 | Expired |
| US7410969B2 | Antitumoral analogs of ET-743 | Chemistry; Metallurgy | 18 | Expired |
| US7241892B1 | Hemisynthetic method and new compounds | Emerging Cross-Sectional Technologies | 18 | Expired |
| US7524956B2 | Hemisynthetic method and new compounds | Emerging Cross-Sectional Technologies | 17 | Active |
| US7247629B2 | Antitumoral analogs of et-743 | Chemistry; Metallurgy | 16 | Expired |
| US7420051B2 | Synthetic process for the manufacture of an ecteinaschidin compound | Chemistry; Metallurgy | 16 | Active |
| US7622458B2 | Combination of ET-743 and a 5-fluorouracil pro-drug for cancer treatment | Human Necessities | 15 | Expired |
| US5834586A | Dehydrodidemnin B | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6710029B1 | Dehydrodidemnin B | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6153731A | Dehydrodidemnin B | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6544560B1 | Culture of sessile marine animals | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5852033A | Methods of treatment using lamellarin-class alkaloids | Human Necessities | 11 | Expired |
| US7115743B2 | Metabolites of ecteinascidin 743 | Chemistry; Metallurgy | 11 | Expired |
| US7723068B2 | Gene cluster involved in safracin biosynthesis and its uses for genetic engineering | Chemistry; Metallurgy | 10 | Expired |
| US6011010A | Cytotoxic and antiviral compound | Human Necessities | 10 | Expired |
| US7135494B2 | Antitumoral carbazoles | Human Necessities | 9 | Expired |
| US7767659B2 | Synthesis of naturally occurring ecteinascidins and related compounds | Chemistry; Metallurgy | 9 | Expired |
| US5834505A | Antimalarial drugs | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7329666B2 | Derivatives of variolin B | Human Necessities | 9 | Expired |
| US7763615B2 | Ecteinascidin analogs for use as antitumour agents | Human Necessities | 8 | Expired |
| US7507766B2 | Treatment of cancers | Human Necessities | 8 | Expired |
| US8420130B1 | Pharmaceutical formulation of a didemnin compound | Human Necessities | 8 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.